Kenvue’s Debt Restructuring Accelerates with Third Supplemental Indenture as Exchange Offer Launches

Kenvue Inc. (NYSE: KVUE), the consumer health company known for brands like Tylenol®, Neutrogena®, and Band‑Aid®, has enacted a material advance in its capital structure strategy. On October 9, 2026, Kenvue entered into a Third Supplemental Indenture to its pre‑existing bond indenture, affecting all seven series of its senior notes. This amendment adjusts terms for its outstanding debt, which includes instruments maturing as far out as 2063. At the same time, Kimberly‑Clark, Kenvue’s pending acquirer, has initiated exchange offers and consent solicitations targeting eligible noteholders to adopt changes such as removing restrictive covenants, loosening default triggers, and eliminating SEC reporting obligations under the indenture.

The Third Supplemental Indenture, filed on October 13 in an 8‑K report covering the event dated October 9, formalizes the amendment to the existing indenture that governs Kenvue’s senior notes due across multiple maturities. This move comes amid the pending merger, under which Kimberly‑Clark agreed to acquire Kenvue in a cash and stock transaction announced in November 2025. The exchange offers are set to expire at 5 p.m. New York time on October 27, unless extended or terminated.

The synchronization of the indenture amendment and the launch of the exchange offers underscores Kimberly‑Clark’s effort to streamline Kenvue’s debt framework ahead of closing. Eliminating restrictive covenants and reporting requirements may yield enhanced financial flexibility post-acquisition. However, these actions remain non‑binding until noteholder consent thresholds are met.

Investors should take note of this strategic financing development, even though Kenvue’s share price briefly reflected this activity; per live market data, KVUE was trading at $19.04 as of October 21, having experienced a 0.99% daily decline. No direct causation between the indenture amendment, the consent solicitations, and the share price movement has been established.

Implications and Next Steps

These debt adjustments suggest that Kimberly‑Clark is proactively preparing the ground for closing the acquisition by reshaping Kenvue’s balance sheet. The elimination of covenants and reporting requirements could simplify integration. Key upcoming milestones include:

• Whether noteholders will supply the necessary consents before the October 27 deadline.
• Whether these changes influence debt refinancing or capital allocation under new ownership.
• The status of regulatory approvals and shareholder votes needed to finalize the Kimberly‑Clark acquisition.

Overall, the Third Supplemental Indenture and accompanying exchange offer represent significant structural steps in the progression of Kenvue’s merger path.